BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34053968)

  • 1. The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report.
    Mori Y; Izumiyama T; Mori N; Aizawa T
    Tohoku J Exp Med; 2021 May; 254(1):57-61. PubMed ID: 34053968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report.
    Lamy O; Gonzalez-Rodriguez E; Stoll D; Hans D; Aubry-Rozier B
    J Clin Endocrinol Metab; 2017 Feb; 102(2):354-358. PubMed ID: 27732330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation.
    Anastasilakis AD; Polyzos SA; Makras P; Trovas G; Yavropoulou MP; Tournis S
    J Clin Densitom; 2021; 24(4):591-596. PubMed ID: 33541775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
    Clifton Goldney D; Pelegrin C; Jerkovich F; Longobardi V; Gonzalez Rodriguez E; Zanchetta MB
    Osteoporos Int; 2024 Jan; 35(1):165-171. PubMed ID: 37702746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Kono T; Sudo A
    Osteoporos Int; 2018 Mar; 29(3):769-772. PubMed ID: 29230512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
    Lamy O; Fernández-Fernández E; Monjo-Henry I; Stoll D; Aubry-Rozier B; Benavent-Núñez D; Aguado P; Gonzalez-Rodriguez E
    Osteoporos Int; 2019 May; 30(5):1111-1115. PubMed ID: 30613866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough.
    Anastasilakis AD; Trovas G; Balanika A; Polyzos SA; Makras P; Tournis S
    J Clin Densitom; 2021; 24(2):338-340. PubMed ID: 33218880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
    Jeon S; Yu D; Kim S; Kim SW; Jeon I
    Osteoporos Int; 2024 May; 35(5):795-804. PubMed ID: 38261013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Rebound-Associated Vertebral Fractures after Denosumab Discontinuation: Is Prompt Antiresorptive Therapy Always Recommended,Even When the Risk of Fracture Seems Low? A Case Report.
    Osella G; Puglisi S; Alì A; Reimondo G; Terzolo M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2303-2306. PubMed ID: 34238202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Popp AW; Zysset PK; Lippuner K
    Osteoporos Int; 2016 May; 27(5):1917-21. PubMed ID: 26694598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Aubry-Rozier B; Gonzalez-Rodriguez E; Stoll D; Lamy O
    Osteoporos Int; 2016 May; 27(5):1923-5. PubMed ID: 26510845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping Denosumab.
    Lamy O; Stoll D; Aubry-Rozier B; Rodriguez EG
    Curr Osteoporos Rep; 2019 Feb; 17(1):8-15. PubMed ID: 30659428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Ha J; Kim J; Jeong C; Lim Y; Kim MK; Kwon HS; Song KH; Kang MI; Baek KH
    Osteoporos Int; 2022 Jul; 33(7):1591-1599. PubMed ID: 35376989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second rebound-associated vertebral fractures after denosumab discontinuation.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Kono T; Sudo A
    Arch Osteoporos; 2020 Jan; 15(1):7. PubMed ID: 31898803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.
    Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Bisbinas I; Katsarou A; Filippaios A; Mantzoros CS
    Osteoporos Int; 2014 May; 25(5):1633-42. PubMed ID: 24599275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.
    Hadji P; Zanchetta JR; Russo L; Recknor CP; Saag KG; McKiernan FE; Silverman SL; Alam J; Burge RT; Krege JH; Lakshmanan MC; Masica DN; Mitlak BH; Stock JL
    Osteoporos Int; 2012 Aug; 23(8):2141-50. PubMed ID: 22159672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study.
    Ijuin A; Yoshikata H; Asano R; Tsuburai T; Kikuchi R; Sakakibara H
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):863-866. PubMed ID: 29241936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.